Overview
Ryoichi Ishibashi practices in Kisarazu, Japan. Ishibashi is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Diabetic Macular Edema (DME), Type 2 Diabetes (T2D), Diabetic Retinopathy, and Lymphomatoid Granulomatosis.
Their clinical research consists of co-authoring 37 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Diabetic Macular Edema (DME)Ishibashi isAdvanced. Learn about Diabetic Macular Edema (DME).
- Type 2 Diabetes (T2D)Ishibashi isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Age-Related Macular Degeneration (ARMD)
- AtherosclerosisIshibashi isExperienced. Learn about Atherosclerosis.
- Cyclothymic DisorderIshibashi isExperienced. Learn about Cyclothymic Disorder.
- Diabetic NephropathyIshibashi isExperienced. Learn about Diabetic Nephropathy.
- Diabetic RetinopathyIshibashi isExperienced. Learn about Diabetic Retinopathy.
- Fish-Eye DiseaseIshibashi isExperienced. Learn about Fish-Eye Disease.